Jason O'Byrne

EVP & Chief Financial Officer, Vir Biotechnology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Feb 24, 2026

Companies

Vir Biotechnology, Inc.EVP & Chief Financial Officer −$0.1M

Trades

VIR Sold 1,634 shares at $9.53 · planned $0.0M Feb 24

VIR Sold 2,089 shares at $7.45 · planned $0.0M Feb 23

VIR Sold 6,799 shares at $5.56 · planned $0.0M Nov 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.